Rebecca Begley, Ph.D.
VP, Program and Alliance Management

Dr. Begley brings 20 years of biotech experience across a range of fields and therapeutic areas.

Before joining Terns, Dr. Begley was Director of Clinical Pharmacology at Gilead Sciences where she oversaw Clinical Pharmacology programs in the long-acting HIV and HIV cure portfolio. She has held roles in Research, Clinical Pharmacology and Project Management, supporting programs from early research, through to NDA.

Dr. Begley completed her bachelor's degree in Biochemistry from Barnard College, Columbia University, and her Ph.D. in Molecular Pharmacology from Stanford University.